CClinicalTrials.gg
CompletedNCT03853590Updated Feb 25, 2019

Improvement of Insulin Resistance After Bariatric Surgery

An interventional study of Roux-en-Y gastric bypass and Laparoscopic adjustable gastric banding in Obesity, Bariatric Surgery Candidate and Insulin Tolerance, sponsored by Beth Israel Deaconess Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-02-25.

Sponsored by Beth Israel Deaconess Medical Center · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 8 years 11 months after the study started (first participant enrolled Feb 2010, registered Feb 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Non-randomized open label study to investigate factors mediating changes in insulin sensitivity, glucose tolerance and other metabolic outcomes after bariatric surgery.

Read the detailed description

Bariatric and weight loss surgery is an effective treatment for severe obesity. Bariatric surgery also decreases insulin resistance and improves diabetes. Our study enrolled individuals approved for bariatric surgery to collect data on modifiable predictors and laboratory outcomes. These data would allow us to systematically assess clinical outcomes over one year post bariatric surgery and elucidate how insulin resistance is decreased and diabetes is improved.

The type of surgery was selected by the subjects between Roux-en-Y gastric bypass or a laparoscopic adjustable gastric banding. Participation in the study involved having a small sample of tissue obtained from the abdomen and subjects were also given the option to have a biopsy performed in the thigh area during their elective surgical procedure (optional adipose and muscle tissue biopsies).

Subjects were examined prior to surgery and at 2, 3, 6 months after intervention. Anthropometric and body composition measurements were performed using the Bioelectrical Impendence Analysis (BIA) before surgery and 6 months post operatively. Morning blood was collected after overnight fasting during each visit. Some of the non-diabetic subjects completed a mixed nutrient stimulation study during the baseline and 6-month visit. Blood samples were collected immediately prior to drinking the liquid drink, and every 30 minutes after the meal ingestion for 2 hours.

02

Conditions studied

  • Obesity
  • Bariatric Surgery Candidate
  • Insulin Tolerance

Browse trials for

03

In context

Insulin Resistance

1,962 studies on the registry are indexed under Insulin Resistance; 307 are open to participants now.

This study's enrollment of 42 is close to the median of 40 across 1,538 interventional studies indexed under Insulin Resistance.

Browse Insulin Resistance studies →

Lead sponsor

Beth Israel Deaconess Medical Center is the lead sponsor of 560 studies on the registry; 80 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 61 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  1. males and females
  2. 18-65 years old
  3. approved for bariatric surgery as per BIDMC Bariatric Clinic guidelines
  4. English-speaking
  5. willing and able to take part in a multi year study involving telephone interviews and enrolled prior to bariatric surgery

Exclusion Criteria:

  1. Any condition that would exclude a patient from bariatric surgery as listed below:

    1. patients with untreated major depression or psychosis
    2. binge eating disorders
    3. current drug and alcohol abuse
    4. severe cardiac disease with prohibitive anesthetic risks
    5. severe coagulopathy
    6. inability to comply with nutritional requirements including life-long vitamin replacement.
    7. pregnancy
  2. Any additional condition not in accordance with standard of care as per Bariatric Clinic at BIDMC.
  3. Any condition which in the opinion of the investigators rendered the candidate unsuitable for participation in this study.

Exclusion Criteria for Optional Biopsy:

  1. history of any illness, other than obesity, that may affect insulin sensitivity (diabetes anemia, infectious diseases, renal or hepatic failure, uncontrolled hypertension, cancer or lymphoma)
  2. subjects who required special diet prior to surgery
  3. chronic inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis
  4. states of cortisol or growth hormone excess
  5. any medications that are known to influence glucose metabolism such as glucocorticoids
  6. a known history of anaphylaxis or anaphylactoid-like reactions or who have a known hypersensitivity to anesthetic agents such as Lidocaine or Novocaine
  7. a known history of bleeding dyscrasia or poor wound healing
  8. any medical condition precluding supine position
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Active comparator
    Laparoscopic Adjustable Gastric Band

    Subjects who elected to undergo Laparoscopic Adjustable Gastric Band intervention were examined prior to surgery and at 2, 3, 6 months after operation.

    Procedure: Laparoscopic adjustable gastric banding

  • Experimental
    Roux-en-Y gastric bypass surgery

    Subjects who elected to undergo Roux-en-Y gastric bypass surgery were examined prior to surgery and at 2, 3, 6 months after operation.

    Procedure: Roux-en-Y gastric bypass

Interventions

  • ProcedureRoux-en-Y gastric bypass

    Creation of a small pouch from the stomach and connection of the newly created pouch directly to the small intestine so that swallowed food bypasses most of the stomach and the first section of the small intestine.

  • ProcedureLaparoscopic adjustable gastric banding

    Placement of a soft silicone ring with an expandable balloon in the center, around the top part of the stomach to create a two-compartment stomach, with a much smaller top part above the band. The subject will eat enough food only to fill the top part of the stomach decreasing caloric consumption.

06

What researchers measure

Primary outcomes

  1. fasting insulin

    circulating levels of fasting insulin measured in pmol/L

    Time frame: Change from Baseline insulin at 6 months post-surgery

  2. fasting glucose

    circulating levels of fasting glucose measured in mg/dl

    Time frame: Change from Baseline insulin at 6 months post-surgery

  3. Boost Challenge Test

    serum insulin and glucose levels after a mixed meal challenge (Boost Protein shake)

    Time frame: Change from Baseline insulin at 6 months post-surgery

07

Study locations

1 site
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03853590
Lead sponsor
Beth Israel Deaconess Medical Center
Responsible party
Christos Mantzoros (Principal Investigator, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
Feb 25, 2019
Start date
Feb 25, 2010
Primary completion
Apr 1, 2013
Completion
May 1, 2015
Last update
Feb 25, 2019

Study contacts

Christos Mantzoros, MD, PhD
principal investigator · Beth Israel Deaconess Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion